FI850940L - Foerfarande foer inaktivering av foeroekningsdugliga filterbara sjukdomsalstrare i blodprodukter. - Google Patents

Foerfarande foer inaktivering av foeroekningsdugliga filterbara sjukdomsalstrare i blodprodukter.

Info

Publication number
FI850940L
FI850940L FI850940A FI850940A FI850940L FI 850940 L FI850940 L FI 850940L FI 850940 A FI850940 A FI 850940A FI 850940 A FI850940 A FI 850940A FI 850940 L FI850940 L FI 850940L
Authority
FI
Finland
Prior art keywords
filterbara
sjukdomsalstrare
foeroekningsdugliga
inaktivering
blodprodukter
Prior art date
Application number
FI850940A
Other languages
English (en)
Other versions
FI850940A0 (fi
FI81720B (fi
FI81720C (fi
Inventor
Johann Eibl
Otto Schwarz
Fritz Elsinger
Guenter Woeber
Anton Philapitsch
Yendra Linnau
Friedrich Dorner
Karl Trambauer
Wolfgang Frechinger
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to AT0079284A priority Critical patent/AT385657B/de
Priority to AT79284 priority
Priority to AT323784 priority
Priority to AT0323784A priority patent/AT389815B/de
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI850940A0 publication Critical patent/FI850940A0/fi
Publication of FI850940L publication Critical patent/FI850940L/fi
Application granted granted Critical
Publication of FI81720B publication Critical patent/FI81720B/fi
Publication of FI81720C publication Critical patent/FI81720C/fi
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25593930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI850940(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04Heat
FI850940A 1984-03-09 1985-03-08 Foerfarande foer inaktivering av oekningsbenaegna filterbara sjukdomsalstrare i blodprodukter. FI81720C (fi)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AT0079284A AT385657B (de) 1984-03-09 1984-03-09 Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
AT79284 1984-03-09
AT323784 1984-10-11
AT0323784A AT389815B (de) 1984-03-09 1984-10-11 Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten

Publications (4)

Publication Number Publication Date
FI850940A0 FI850940A0 (fi) 1985-03-08
FI850940L true FI850940L (fi) 1985-09-10
FI81720B FI81720B (fi) 1990-08-31
FI81720C FI81720C (fi) 1990-12-10

Family

ID=25593930

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850940A FI81720C (fi) 1984-03-09 1985-03-08 Foerfarande foer inaktivering av oekningsbenaegna filterbara sjukdomsalstrare i blodprodukter.

Country Status (9)

Country Link
US (1) US4640834A (fi)
EP (1) EP0159311B1 (fi)
JP (1) JPH0739348B2 (fi)
AT (2) AT389815B (fi)
CA (1) CA1239583A (fi)
DE (1) DE3569473D1 (fi)
DK (1) DK162966C (fi)
ES (1) ES8802273A1 (fi)
FI (1) FI81720C (fi)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
AT390001B (de) * 1984-09-28 1990-03-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
EP0212040B1 (de) * 1985-08-05 1990-05-23 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Herstellung von Präparationen auf Basis von Blutgerinnungsfaktoren
EP0225581A3 (en) * 1985-11-30 1989-05-24 Green Cross Corporation Method for the heat-treatment of immunoglobulins and immunoglobulin product
DK595285D0 (da) * 1985-12-20 1985-12-20 Nordisk Gentofte Injicerbart og varmebehandet igg-praeparat og fremgangsmaade til fremstilling af samme
AT390374B (de) * 1986-03-18 1990-04-25 Schwab & Co Gmbh Verfahren zum pasteurisieren von plasmaprotein und plasmaproteinfraktionen
US4762714A (en) * 1986-04-08 1988-08-09 Miles Laboratories, Inc. Preparation of retrovirus-free immunoglobulins
US5159064A (en) * 1986-04-08 1992-10-27 Miles Inc. Preparation of virus-free antibodies
US4948877A (en) * 1986-04-08 1990-08-14 Miles Laboratories, Inc. Preparation of retrovirus-free immunoglobulins
US5419906A (en) * 1986-04-08 1995-05-30 Miles Inc. Preparation of human immunoglobulin free of hepatitis C
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US5248767A (en) * 1986-06-11 1993-09-28 Behringwerke Aktiengesellschaft Process for the preparation of a pasteurized immunoglobulin preparation using ethanol
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
AU2251288A (en) * 1987-05-15 1988-12-06 Alan I. Rubinstein Sequential improved method for treatment of human blood- clotting factor products
US5260420A (en) * 1987-07-30 1993-11-09 Centre Regional De Transfusion Sanguine De Lille Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
FR2618784B1 (fr) * 1987-07-30 1990-04-06 Lille Transfusion Sanguine Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique
JP2613409B2 (ja) * 1987-11-20 1997-05-28 株式会社ミドリ十字 抗エイズウイルス抗体陽性静注用免疫グロブリン製剤の製造方法
AT391809B (de) * 1988-01-12 1990-12-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutplasmaprodukten
US5484396A (en) * 1988-11-17 1996-01-16 Naficy; Sadeque S. Method and device for treatment of HIV infections and AIDS
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
WO1994013329A1 (de) * 1992-12-16 1994-06-23 Immuno Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4325872C1 (de) * 1993-08-02 1994-08-04 Immuno Ag Virusinaktivierte Faktor Xa-Präparation
AT402788B (de) * 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation
DE4404625C2 (de) * 1994-02-14 1996-10-17 Ludwig Dr Baumgartner Verfahren zur Inaktivierung thermolabiler Viren in biologischem Material unter Beibehaltung der kollagenen Eigenschaften
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel
DE4416180C2 (de) * 1994-05-06 1997-08-14 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen und Verfahren zur Herstellung dieses Präparats
US6017891A (en) * 1994-05-06 2000-01-25 Baxter Aktiengesellschaft Stable preparation for the treatment of blood coagulation disorders
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
DE4424935C1 (de) 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
DE19521324C1 (de) * 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
US5863896A (en) 1995-11-09 1999-01-26 Immuno Ag Evaluation of substances for altering and for increasing APC response
US6005077A (en) * 1995-11-10 1999-12-21 Immuno Aktiengesellschaft Use of von willebrand factor and pharmaceutical formulation
DE19600939C1 (de) 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
CZ81997A3 (en) * 1996-03-20 1997-10-15 Immuno Ag Pharmaceutical preparation for treating disorders connected with blood clotting, process of its preparation and use
US6068838A (en) * 1996-04-29 2000-05-30 Baxter Aktiengesellschaft Purified multimerase
DE19617369A1 (de) * 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
US6632648B1 (en) * 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
AU5082698A (en) * 1996-10-23 1998-05-15 Oravax, Inc Heat inactivation of viruses in antibody preparations
AT405135B (de) 1997-01-17 1999-05-25 Immuno Ag Präparation umfassend thiolgruppen-hältige proteine
AT404358B (de) 1997-02-04 1998-11-25 Immuno Ag Verfahren zur chromatographischen reinigung bzw. fraktionierung von von willebrand-faktor aus einem vwf-hältigen ausgangsmaterial
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT406120B (de) 1997-08-28 2000-02-25 Immuno Ag Gewebekleber
AT405739B (de) 1997-09-19 1999-11-25 Immuno Ag Verfahren zur reinigung von antithrombin iii
EP1151007B1 (en) * 1999-02-12 2006-05-03 Baxter Aktiengesellschaft A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method
DK1820516T3 (da) 1999-02-22 2013-10-28 Univ Connecticut Nye albuminfrie faktor VIII-præparater
AT410218B (de) 1999-08-20 2003-03-25 Baxter Ag Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben
FR2806910B1 (fr) * 2000-04-03 2003-01-24 Dolisos Lab Procede d'inactivation virale de solutions hydro-alcooliques
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7795218B2 (en) 2001-04-12 2010-09-14 Bioaxone Therapeutique Inc. ADP-ribosyl transferase fusion variant proteins
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
ES2404682T3 (es) 2003-12-11 2013-05-28 Isto Technologies Inc. Sistema de cartílago particulado
AU2006282754A1 (en) 2005-08-26 2007-03-01 Zimmer, Inc. Implants and methods for repair, replacement and treatment of joint disease
US8703122B2 (en) * 2006-05-31 2014-04-22 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
US8623842B2 (en) * 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US20080154233A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Apparatus for delivering a biocompatible material to a surgical site and method of using same
CA2684040C (en) * 2007-04-12 2016-12-06 Isto Technologies, Inc. Method of forming an implant using a mold that mimics the shape of the tissue defect site and implant formed therefrom
WO2009021708A2 (en) 2007-08-13 2009-02-19 Baxter International Inc. Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease
ES2662647T3 (es) 2007-10-30 2018-04-09 Baxter International Inc. Uso de una biomatriz de colágeno biofuncional regenerativa para tratar defectos viscerales o parietales
EP2259803B2 (en) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9061087B2 (en) * 2008-03-04 2015-06-23 Hemostasis, Llc Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
BRPI0921429A2 (pt) 2008-11-07 2016-01-05 Baxter Int formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
US9039783B2 (en) * 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
AU2010262058B2 (en) * 2009-06-16 2013-08-29 Baxter Healthcare S.A. Hemostatic sponge
US20110052663A1 (en) * 2009-09-01 2011-03-03 Hemostasis, Llc Hemostatic Sponge with Enzyme and Method of Manufacture
KR101811070B1 (ko) * 2009-12-16 2017-12-20 백스터 인터내셔널 인코포레이티드 지혈 스폰지
US8703170B2 (en) 2010-04-07 2014-04-22 Baxter International Inc. Hemostatic sponge
JP5973997B2 (ja) 2010-06-01 2016-08-23 バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated 乾燥した安定な止血用組成物を作製するためのプロセス
KR101957625B1 (ko) 2010-06-01 2019-03-12 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
MX352875B (es) 2010-06-01 2017-12-13 Baxter Healthcare Sa Proceso para elaborar composiciones hemostaticas secas y estables.
KR20140074990A (ko) 2011-10-11 2014-06-18 백스터 인터내셔널 인코포레이티드 지혈 조성물
MX356185B (es) 2011-10-11 2018-05-17 Baxter Int Composiciones hemostaticas.
AU2012330450B2 (en) 2011-10-27 2017-04-27 Baxter Healthcare Sa Hemostatic compositions
PT2820042T (pt) 2012-02-29 2019-10-31 Baxalta Inc Remielinização estimulada por igg de nervos periféricos
WO2013185776A1 (en) 2012-06-12 2013-12-19 Ferrosan Medical Devices A/S Dry haemostatic composition
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
CN105358071B (zh) 2013-06-21 2018-07-31 弗罗桑医疗设备公司 真空膨胀的干组合物和用于保留该干组合物的注射器
RU2678592C1 (ru) 2013-12-11 2019-01-30 Ферросан Медикал Дивайсиз А/С Сухая композиция, содержащая компонент, улучшающий экструзию
BR112017013565A2 (pt) 2014-12-24 2018-03-06 Ferrosan Medical Devices As seringa para retenção e mistura de primeira e segunda substâncias.

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361732A (en) * 1964-07-28 1968-01-02 Dow Chemical Co Method for concentration of blood protein solutions employing methanol and flash evaporation
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
US4250139A (en) * 1979-02-01 1981-02-10 Collagen Corporation Microwave sterilization of dry protein
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
JPS572687A (en) * 1980-06-06 1982-01-08 Ajinomoto Co Inc Preparation of l-isoleucine by fermentation
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3043857A1 (de) * 1980-11-21 1982-07-08 Behringwerke Ag Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ii und vii
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
JPH0348169B2 (fi) * 1981-02-25 1991-07-23 Green Cross Corp
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions
JPH0348170B2 (fi) * 1981-10-28 1991-07-23 Green Cross Corp
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4379085A (en) * 1982-05-14 1983-04-05 American National Red Cross Heat stabilization of plasma proteins
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors

Also Published As

Publication number Publication date
ES540919A0 (es) 1988-05-01
FI850940A0 (fi) 1985-03-08
DK162966C (da) 1992-05-25
ES540919D0 (fi)
DE3569473D1 (en) 1989-05-24
ATA323784A (de) 1989-07-15
AT389815B (de) 1990-02-12
DK107185D0 (da) 1985-03-08
US4640834A (en) 1987-02-03
CA1239583A (en) 1988-07-26
DK162966B (da) 1992-01-06
EP0159311B1 (de) 1989-04-19
EP0159311A1 (de) 1985-10-23
FI850940D0 (fi)
FI81720C (fi) 1990-12-10
FI850940A (fi)
JPH0739348B2 (ja) 1995-05-01
FI81720B (fi) 1990-08-31
AT42205T (de) 1989-05-15
CA1239583A1 (fi)
DK107185A (da) 1985-09-10
ES8802273A1 (es) 1988-05-01
JPS60215628A (en) 1985-10-29

Similar Documents

Publication Publication Date Title
FI852831L (fi) Foerfarande foer framstaellning av sjaelvbaerande keramiska aemnen.
FI850040L (fi) Foerfarande foer fodring av roerledningar.
FI852265A0 (fi) Anordning foer oskillerande lineardrift av konstruktionsdelar.
FI841500A0 (fi) Foerfarande foer uppbygnande av cellulolytiska jaeststammar.
FI861843A (fi) Drivanordning foer borrstaong speciellt foer utfoerande av kontinuerlig djupborrning.
FI844046A0 (fi) Foerfarande foer framstaellning av polytriaziner fraon aromatiska polycyanater.
FI861137A (fi) Foerlaengd lagring av roeda blodceller.
FI854802A0 (fi) Verktyg av modulkonstruktion foer drivning av faesten.
FI851803L (fi) Anordning foer avgivning av en flyktig effektivsubstans.
FI853278A0 (fi) Foerfarande foer framstaellning av soetsaksstaenger innehaollande graeddvaofflor.
FI862012A0 (fi) Foerfarande foer framstaellning av myrsyra.
FI851738A0 (fi) Foerhandsupptagningssystem av en order foer villkorlig hoppinstruktion i en centralprocessorenhet.
FI83882B (fi) Foerfarande foer framstaellning av blodlevring haemmande proteiner.
FI860032A (fi) Behandling av metaller.
FI851616A0 (fi) Framstaellning av polymer-polyoler.
FI855153A0 (fi) Olefinisk terpolymerisering av gasfluidiserad-baedd-foerfarande.
FI850940L (fi) Foerfarande foer inaktivering av foeroekningsdugliga filterbara sjukdomsalstrare i blodprodukter.
FI854130A0 (fi) Foerfarande foer framstaellning av spaon- eller fiberplattor.
FI852312L (fi) Framstaellning av en matprodukt.
FI872033A (fi) Anordning foer stoed av benfrakturer.
FI86252B (fi) Foerfarande foer foerbaettring av en antracyklinglykosids upploesbarhet i en foer injektering laemplig loesningsmedelsblandning.
FI852066A0 (fi) Foerfarande foer framstaellning av en foerform foer dragande av ljusledningsfibrer.
FI851941A0 (fi) Foerfarande foer framstaellning av 7 -halogen-7-deoxilinkomycin.
FI850164A0 (fi) Vaotpress foer avlaegsnande av vaetska fraon en varubana.
FI854869A (fi) Foerfarande foer framstaellning av foerbaettrad kakao.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: "IMMUNO" AKTIENGESELLSCHAFT FUER